Literature DB >> 181777

The economic impact of viral hepatitis in the United States.

D D Tolsma, J A Bryan.   

Abstract

Entities:  

Mesh：

Year:  1976        PMID： 181777      PMCID： PMC1440543     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  11 in total

1.  RISK OF POST-TRANSFUSION VIRAL HEPATITIS.

Authors:  G F GRADY; T C CHALMERS
Journal:  N Engl J Med       Date:  1964-08-13       Impact factor: 91.245

2.  NATIONAL SURVEY OF VENEREAL DISEASE TREATMENT.

Authors:  A C CURTIS
Journal:  JAMA       Date:  1963-10-05       Impact factor: 56.272

3.  VIRAL HEPATITIS IN A GROUP OF BOSTON HOSPITALS. I. A RETROSPECTIVE STUDY OF 1675 PATIENTS.

Authors:  G F GRADY; T C CHALMERS
Journal:  N Engl J Med       Date:  1965-04-01       Impact factor: 91.245

4.  Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus.

Authors:  A M Prince; B Brotman; G F Grady; W J Kuhns; C Hazzi; R W Levine; S J Millian
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

5.  The changing epidemiology of viral hepatitis in the United States.

Authors:  M B Gregg
Journal:  Am J Dis Child       Date:  1972-04

6.  Benefits due to immunization against measles.

Authors:  N W Axnick; S M Shavell; J J Witte
Journal:  Public Health Rep       Date:  1969-08       Impact factor: 2.792

7.  The Holy Cross college football team hepatitis outbreak.

Authors:  L J Morse; J A Bryan; J P Hurley; J F Murphy; T F O'Brien; W E Wacker
Journal:  JAMA       Date:  1972-02       Impact factor: 56.272

8.  Risk of posttransfusion hepatitis in the United States. A prospective cooperative study.

Authors:  G F Grady; A J Bennett
Journal:  JAMA       Date:  1972-05-01       Impact factor: 56.272

9.  Eight years of surveillance of patients hospitalized with hepatitis: interpretation of data in light of epidemic parenteral drug abuse and availability of testing for hepatitis-associated antigen.

Authors:  G F Grady; A J Bennett; P O Culhane; J N Forrest; F L Iber
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

Review 10.  Viral hepatitis: a group of epidemiologic entities.

Authors:  J W Mosley
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262
View more
  8 in total

1.  Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.

Authors:  G M Ginsberg; D Shouval
Journal:  J Epidemiol Community Health       Date:  1992-12       Impact factor: 3.710

2.  Benefit-cost analysis of active surveillance of primary care physicians for hepatitis A.

Authors:  M W Hinds; J W Skaggs; G H Bergeisen
Journal:  Am J Public Health       Date:  1985-02       Impact factor: 9.308

3.  Syringe-transmitted hepatitis.

Authors:  A J Zuckerman
Journal:  Br Med J       Date:  1978-10-14

Review 4.  Viral hepatitis and the anaesthetist.

Authors:  R A Browne; M A Chernesky
Journal:  Can Anaesth Soc J       Date:  1984-05

5.  Assessment of immunoglobulin use for hepatitis A control in New Mexico.

Authors:  J M Mann; D P Francis; R E Hoffman; J Montes
Journal:  Public Health Rep       Date:  1982 Nov-Dec       Impact factor: 2.792

6.  Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.

Authors:  G M Ginsberg; S Berger; D Shouval
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

Review 7.  Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A.

Authors:  Jeroen Luyten; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Vehicular carbon monoxide screening: identification in a cross-cultural setting of a substantial public health risk factor.

Authors:  R L Williams
Journal:  Am J Public Health       Date:  1985-01       Impact factor: 9.308
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.